Whittier Trust’s Theravance Biopharma TBPH Stock Holding History

Whittier Trust’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-289	Closed	-$3.19K	–	1595
2025 Q2	$3.19K	Hold	289	–	–	﹤0.01%	1383
2025 Q1	$2.58K	Hold	289	–	–	﹤0.01%	1382
2024 Q4	$2.72K	Hold	289	–	–	﹤0.01%	1430
2024 Q3	$2.33K	Hold	289	–	–	﹤0.01%	1443
2024 Q2	$2.45K	Hold	289	–	–	﹤0.01%	1421
2024 Q1	$2.59K	Hold	289	–	–	﹤0.01%	1405
2023 Q4	$3.25K	Hold	289	–	–	﹤0.01%	1367
2023 Q3	$2.49K	Hold	289	–	–	﹤0.01%	1445
2023 Q2	$2.99K	Hold	289	–	–	﹤0.01%	1422
2023 Q1	$3.13K	Hold	289	–	–	﹤0.01%	1449
2022 Q4	$3.24K	Hold	289	–	–	﹤0.01%	1441
2022 Q3	$3K	Hold	289	–	–	﹤0.01%	1535
2022 Q2	$3K	Hold	289	–	–	﹤0.01%	1523
2022 Q1	$3K	Hold	289	–	–	﹤0.01%	1539
2021 Q4	$3K	Hold	289	–	–	﹤0.01%	1479
2021 Q3	$2K	Hold	289	–	–	﹤0.01%	1430
2021 Q2	$4K	Hold	289	–	–	﹤0.01%	1393
2021 Q1	$6K	Hold	289	–	–	﹤0.01%	1330
2020 Q4	$5K	Hold	289	–	–	﹤0.01%	1251
2020 Q3	$4K	Hold	289	–	–	﹤0.01%	1273
2020 Q2	$6K	Hold	289	–	–	﹤0.01%	1145
2020 Q1	$7K	Hold	289	–	–	﹤0.01%	1171
2019 Q4	$7K	Hold	289	–	–	﹤0.01%	1190
2019 Q3	$6K	Hold	289	–	–	﹤0.01%	1233
2019 Q2	$5K	Sell	289 -195	-40%	-$3.95K	﹤0.01%	1157
2019 Q1	$11K	Hold	484	–	–	﹤0.01%	1051
2018 Q4	$12K	Hold	484	–	–	﹤0.01%	1070
2018 Q3	$16K	Hold	484	–	–	﹤0.01%	986
2018 Q2	$11K	Hold	484	–	–	﹤0.01%	1019
2018 Q1	$12K	Buy	+484	New	+$13.3K	﹤0.01%	1021

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Whittier Trust's TBPH Position: Q3 2025 in Review

Whittier Trust sold out of Theravance Biopharma (TBPH) in Q3 2025, closing a stake of 289 shares — an estimated $3.19K sold.

Whittier Trust first reported a position in TBPH in Q1 2018 and held it in 30 quarters. The position peaked at $16K in Q3 2018. 162 funds tracked by Wall St. Rank hold TBPH as of Q3 2025.

Whittier Trust reported no remaining Theravance Biopharma position as of Q3 2025 after selling out during the quarter.
Whittier Trust sold 289 Theravance Biopharma shares in Q3 2025, an estimated $3.19K.
Whittier Trust first reported a position in Theravance Biopharma in Q1 2018 and held it in 30 quarters.
Whittier Trust's Theravance Biopharma position peaked at $16K in Q3 2018.
162 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.